funny - we hit a 52 week low on EU trial and results completion, FDA classification, partner in Europe, potential sales in now only 6 months. And trials about to begin in USA.
I think I am going to buy more now. My only concern are the conditions in Europe - but up until Monday TIS had held up very well in the market sell-off since May this year.
Short term noise re: partnering. I think and hope it will settle soon.
Add to My Watchlist
What is My Watchlist?